Order Article Reprints

Gravina GL, Mancini A, Colapietro A, Delle Monache S, Sferra R, Pompili S, Vitale F, Martellucci S, Marampon F, Mattei V, et al. The Brain Penetrating and Dual TORC1/TORC2 Inhibitor, RES529, Elicits Anti-Glioma Activity and Enhances the Therapeutic Effects of Anti-Angiogenetic Compounds in Preclinical Murine Models. Cancers. 2019; 11(10):1604. https://doi.org/10.3390/cancers11101604

Gravina, Giovanni Luca, Andrea Mancini, Alessandro Colapietro, Simona Delle Monache, Roberta Sferra, Simona Pompili, Flora Vitale, Stefano Martellucci, Francesco Marampon, Vincenzo Mattei, and et al. 2019. "The Brain Penetrating and Dual TORC1/TORC2 Inhibitor, RES529, Elicits Anti-Glioma Activity and Enhances the Therapeutic Effects of Anti-Angiogenetic Compounds in Preclinical Murine Models" Cancers 11, no. 10: 1604. https://doi.org/10.3390/cancers11101604

Gravina, G. L., Mancini, A., Colapietro, A., Delle Monache, S., Sferra, R., Pompili, S., Vitale, F., Martellucci, S., Marampon, F., Mattei, V., Biordi, L., Sherris, D., & Festuccia, C. (2019). The Brain Penetrating and Dual TORC1/TORC2 Inhibitor, RES529, Elicits Anti-Glioma Activity and Enhances the Therapeutic Effects of Anti-Angiogenetic Compounds in Preclinical Murine Models. Cancers, 11(10), 1604. https://doi.org/10.3390/cancers11101604